Skip Navigation Skip To Footer

Publications

Randomized Evaluation of Trial Acceptability by Incentive (RETAIN): Study Protocol for Two Embedded Randomized Controlled Trials.

Krutsinger DC, McMahon J, Stephens-Shields AJ, Bayes B, Brooks S, Hitsman BL, Lubitz SF, Reyes C, Schnoll RA, Ryan Greysen S, Mercede A, Patel MS, Reale C, Barg F, Karlawish J, Polsky D, Volpp KG, Halpern SD

Published

November 7th, 2018

Appears In

Contemporary Clinical Trials

External Link

External Link

Abstract

The most common and conceptually sound ethical concerns with financial incentives for research participation are that they may (1) represent undue inducements by blunting peoples' perceptions of research risks, thereby preventing fully informed consent; or (2) represent unjust inducements by encouraging enrollment preferentially among the poor. Neither of these concerns has been shown to manifest in studies testing the effects of incentives on decisions to participate in hypothetical randomized clinical trials (RCTs), but neither has been assessed in real RCTs.

Page 1 Created with Sketch.

We generate high-quality evidence to advance healthcare policies and practices that improve the lives of all people affected by serious illness.